Effect of hamstring flexibility on foot function in plantar fasciopathy

Effects of Hamstring Flossing on Balance and Foot Function in patients with plantar fasciopathy: A Randomized controlled study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202408921930700

Enrollment

Registered

2024-08-08

Start date

2024-07-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

Hamstring Flossing in plantar fasciopathy

Effect of hamstring flossing on balance and foot function in plantar fasciopathy

The effect of conventional physical therapy program on Balance and function in plantar fasciopathy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: They had heel pain and tenderness in the plantar fascia insertion. · They had positive Windlass test. · Their pain score was > 4 out of 10 by using the Visual Analog Scale (VAS). · Their pain was at its highest level during first steps in the morning after waking up and during the walking after period of resting. · Had decreased pain at the onset of activity but worsening as the activity continues. · Their pain level increased by increasing the duration of weight bearing activities. · They had limited hamstring muscle flexibility.

Exclusion criteria

Exclusion criteria: · They had been treated for PF with muscle stretching exercises or night splints during the study. · They received another treatment for PF during the study. · They had history of any trauma or strain at hamstring muscle or the plantar area within the last six months. · Their body Mass Index (BMI) was greater than 35 kg/m². · They had recent ankle sprain. · They had radiating pain confused with neurological pain resulting from spinal problems. · They had Osseous structural changes in the foot (pes planus or pes cavus). · They had been diagnosed with systemic inflammatory disease such as Gout, rheumatoid arthritis, fibromyalgia or neuropathy, neurological diseases, and diseases of the central or peripheral nervous system. · Have latex allergy, hypertension, or venous thrombotic disease.

Design outcomes

Primary

Measure	Time frame
Foot Function Index to measure effect of intervention on foot pain and function;Foot Function Index	—

Secondary

Measure	Time frame
Balance measured by OverAll Stability Index;Over All Stability Index	—

Countries

Egypt

Contacts

Public ContactYassmin Mohamed

Assisstant professor

dryassminessam@gmail.com00201110882022

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026